Literature DB >> 409110

Pharmacology of thyrotropin releasing factor (TRF), luteinizing hormone releasing factor (LRF), and somatostatin.

W Vale, C Rivier, M Brown, J Rivier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 409110     DOI: 10.1007/978-1-4615-8849-8_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

Review 1.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

2.  Peptidergic transmission in sympathetic ganglia of the frog.

Authors:  L Y Jan; Y N Jan
Journal:  J Physiol       Date:  1982-06       Impact factor: 5.182

3.  Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.

Authors:  Christy Rani R Grace; Judit Erchegyi; Steven C Koerber; Jean Claude Reubi; Jean Rivier; Roland Riek
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

4.  Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.

Authors:  Judit Erchegyi; Christy Rani R Grace; Manoj Samant; Renzo Cescato; Veronique Piccand; Roland Riek; Jean Claude Reubi; Jean E Rivier
Journal:  J Med Chem       Date:  2008-04-12       Impact factor: 7.446

5.  Topography of Somatostatin Gene Expression Relative to Molecular Progenitor Domains during Ontogeny of the Mouse Hypothalamus.

Authors:  Nicanor Morales-Delgado; Paloma Merchan; Sylvia M Bardet; José L Ferrán; Luis Puelles; Carmen Díaz
Journal:  Front Neuroanat       Date:  2011-02-28       Impact factor: 3.856

Review 6.  Ventromedial Nucleus of the Hypothalamus Neurons Under the Magnifying Glass.

Authors:  Tansi Khodai; Simon M Luckman
Journal:  Endocrinology       Date:  2021-10-01       Impact factor: 4.736

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.